Vuorela H - Search Results

1

What made sesquiterpene lactones reach cancer clinical trials?

Ghantous A, Gali-Muhtasib H, Vuorela H, Saliba NA, Darwiche N. Ghantous A, et al. Among authors: vuorela h. Drug Discov Today. 2010 Aug;15(15-16):668-78. doi: 10.1016/j.drudis.2010.06.002. Epub 2010 Jun 9. Drug Discov Today. 2010. PMID: 20541036 Review.

2

Reactive oxygen species mediate thymoquinone-induced apoptosis and activate ERK and JNK signaling.

El-Najjar N, Chatila M, Moukadem H, Vuorela H, Ocker M, Gandesiri M, Schneider-Stock R, Gali-Muhtasib H. El-Najjar N, et al. Among authors: vuorela h. Apoptosis. 2010 Feb;15(2):183-95. doi: 10.1007/s10495-009-0421-z. Apoptosis. 2010. PMID: 19882352

3

Impact of protein binding on the analytical detectability and anticancer activity of thymoquinone.

El-Najjar N, Ketola RA, Nissilä T, Mauriala T, Antopolsky M, Jänis J, Gali-Muhtasib H, Urtti A, Vuorela H. El-Najjar N, et al. Among authors: vuorela h. J Chem Biol. 2011 Jul;4(3):97-107. doi: 10.1007/s12154-010-0052-4. Epub 2011 Jan 8. J Chem Biol. 2011. PMID: 22229047 Free PMC article.

4

Corn mint (Mentha arvensis) extract diminishes acute Chlamydia pneumoniae infection in vitro and in vivo.

Salin O, Törmäkangas L, Leinonen M, Saario E, Hagström M, Ketola RA, Saikku P, Vuorela H, Vuorela PM. Salin O, et al. Among authors: vuorela h, vuorela pm. J Agric Food Chem. 2011 Dec 28;59(24):12836-42. doi: 10.1021/jf2032473. Epub 2011 Nov 22. J Agric Food Chem. 2011. PMID: 22073967

5

Formulation and stability of cytokine therapeutics.

Lipiäinen T, Peltoniemi M, Sarkhel S, Yrjönen T, Vuorela H, Urtti A, Juppo A. Lipiäinen T, et al. Among authors: vuorela h. J Pharm Sci. 2015 Feb;104(2):307-26. doi: 10.1002/jps.24243. Epub 2014 Dec 9. J Pharm Sci. 2015. PMID: 25492409 Review.

6

Effects of coadministration of natural polyphenols with doxycycline or calcium modulators on acute Chlamydia pneumoniae infection in vitro.

Salin OP, Pohjala LL, Saikku P, Vuorela HJ, Leinonen M, Vuorela PM. Salin OP, et al. J Antibiot (Tokyo). 2011 Nov;64(11):747-52. doi: 10.1038/ja.2011.79. Epub 2011 Sep 21. J Antibiot (Tokyo). 2011. PMID: 21934693

7

In vivo treatment of acute Chlamydia pneumoniae infection with the flavonoids quercetin and luteolin and an alkyl gallate, octyl gallate, in a mouse model.

Törmäkangas L, Vuorela P, Saario E, Leinonen M, Saikku P, Vuorela H. Törmäkangas L, et al. Among authors: vuorela h, vuorela p. Biochem Pharmacol. 2005 Oct 15;70(8):1222-30. doi: 10.1016/j.bcp.2005.07.012. Biochem Pharmacol. 2005. PMID: 16139801

8

Inhibitory effect of dietary phenolic compounds on Chlamydia pneumoniae in cell cultures.

Alvesalo J, Vuorela H, Tammela P, Leinonen M, Saikku P, Vuorela P. Alvesalo J, et al. Among authors: vuorela h, vuorela p. Biochem Pharmacol. 2006 Mar 14;71(6):735-41. doi: 10.1016/j.bcp.2005.12.006. Epub 2006 Jan 18. Biochem Pharmacol. 2006. PMID: 16414027

9

Mint Flavorings from Candies Inhibit the Infectivity of Chlamydia pneumoniae.

Hanski LL, Kapp K, Tiirola TM, Orav A, Vuorela HJ, Püssa T, Vuorela PM. Hanski LL, et al. Among authors: vuorela hj. Nat Prod Commun. 2016 Nov;11(11):1725-1728. Nat Prod Commun. 2016. PMID: 30475517

10

Dibenzocyclooctadiene lignans from Schisandra spp. selectively inhibit the growth of the intracellular bacteria Chlamydia pneumoniae and Chlamydia trachomatis.

Hakala E, Hanski L, Uvell H, Yrjönen T, Vuorela H, Elofsson M, Vuorela PM. Hakala E, et al. Among authors: vuorela h, vuorela pm. J Antibiot (Tokyo). 2015 Oct;68(10):609-14. doi: 10.1038/ja.2015.48. Epub 2015 May 6. J Antibiot (Tokyo). 2015. PMID: 25944533

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

87 results

Search Page

Filters